Characterization of Renal Microvascular Alterations in Patients With Active Urinary Sediment and/… (NCT07469059) | Clinical Trial Compass
RecruitingNot Applicable
Characterization of Renal Microvascular Alterations in Patients With Active Urinary Sediment and/or Proteinuria Using Ultrasound Localization Microscopy
Germany30 participantsStarted 2025-09-18
Plain-language summary
The goal of this study is the non-invasive visualization and quantification of renal microvascular dynamics in adult kidneys with proteinuria and/or active sediment.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥ 18 years
* Evidence of active urinary sediment and/or proteinuria \>1 g/g creatinine
* Indication for kidney biopsy as part of study-independent diagnostics
* Written informed consent
Exclusion Criteria:
* Known allergic disposition to SonoVue®
* Contraindication to the use of SonoVue®
* Pregnancy
* Breastfeeding mothers
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
CEUS Time intensity curves
Timeframe: baseline and up to 10 weeks after baseline
2
CEUS Measurement1
Timeframe: baseline and up to 10 weeks after baseline
3
CEUS Measurement2
Timeframe: Baseline and up to 10 weeks after baseline
4
CEUS Measurement 3
Timeframe: Baseline and up to 10 weeks after baseline
5
CEUS Measurement5
Timeframe: Baseline and up to 10 weeks after baseline
6
CEUS Measurement6
Timeframe: Baseline and up to 10 weeks after baseline
7
CEUS Measurement7
Timeframe: Baseline and up to 10 weeks after baseline
8
CEUS Measurement8
Trial details
NCT IDNCT07469059
SponsorUniversity of Erlangen-Nürnberg Medical School